Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Evaluation of Fortilink® TETRAfuse® Interbody Fusion Device in Subjects With Degenerative Disc Disease (FORTE)

NCT03761563 is registered in ClinicalTrials.gov with Xtant Medical as lead sponsor.

NCT NCT03761563
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03761563 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Evaluation of Fortilink® TETRAfuse® Interbody Fusion Device in Subjects With Degenerative Disc Disease (FORTE)
Lead sponsor
Xtant Medical
Phase
Observational
Overall status
Completed
Start date
February 13, 2019
Completion date
December 30, 2023
Enrollment
15 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

degenerative disc disease